348 related articles for article (PubMed ID: 27050151)
1. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
[TBL] [Abstract][Full Text] [Related]
2. Translational genomics and recent advances in oral squamous cell carcinoma.
Chai AWY; Lim KP; Cheong SC
Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
[TBL] [Abstract][Full Text] [Related]
3. Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance.
Vincent-Chong VK; Salahshourifar I; Woo KM; Anwar A; Razali R; Gudimella R; Rahman ZA; Ismail SM; Kallarakkal TG; Ramanathan A; Wan Mustafa WM; Abraham MT; Tay KK; Zain RB
PLoS One; 2017; 12(4):e0174865. PubMed ID: 28384287
[TBL] [Abstract][Full Text] [Related]
4. Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.
Su SC; Lin CW; Liu YF; Fan WL; Chen MK; Yu CP; Yang WE; Su CW; Chuang CY; Li WH; Chung WH; Yang SF
Theranostics; 2017; 7(5):1088-1099. PubMed ID: 28435450
[TBL] [Abstract][Full Text] [Related]
5. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
6. Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.
Hayes TF; Benaich N; Goldie SJ; Sipilä K; Ames-Draycott A; Cai W; Yin G; Watt FM
Cancer Lett; 2016 Dec; 383(1):106-114. PubMed ID: 27693639
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization.
Sparano A; Quesnelle KM; Kumar MS; Wang Y; Sylvester AJ; Feldman M; Sewell DA; Weinstein GS; Brose MS
Laryngoscope; 2006 May; 116(5):735-41. PubMed ID: 16652080
[TBL] [Abstract][Full Text] [Related]
9. Mutational signatures and mutagenic impacts associated with betel quid chewing in oral squamous cell carcinoma.
Su SC; Chang LC; Lin CW; Chen MK; Yu CP; Chung WH; Yang SF
Hum Genet; 2019 Dec; 138(11-12):1379-1389. PubMed ID: 31679052
[TBL] [Abstract][Full Text] [Related]
10. The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer.
Foy JP; Tortereau A; Caulin C; Le Texier V; Lavergne E; Thomas E; Chabaud S; Perol D; Lachuer J; Lang W; Hong WK; Goudot P; Lippman SM; Bertolus C; Saintigny P
Oncotarget; 2016 Jun; 7(24):35932-35945. PubMed ID: 27027432
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
Ghantous Y; Bahouth Z; Abu El-Naaj I
Arch Oral Biol; 2018 Nov; 95():141-148. PubMed ID: 30118965
[TBL] [Abstract][Full Text] [Related]
12. Genomic DNA copy number alterations from precursor oral lesions to oral squamous cell carcinoma.
Salahshourifar I; Vincent-Chong VK; Kallarakkal TG; Zain RB
Oral Oncol; 2014 May; 50(5):404-12. PubMed ID: 24613650
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of oral squamous cell carcinomas revealed over expression of ISG15, Nestin and WNT11.
Vincent-Chong VK; Ismail SM; Rahman ZA; Sharifah NA; Anwar A; Pradeep PJ; Ramanathan A; Karen-Ng LP; Kallarakkal TG; Mustafa WM; Abraham MT; Tay KK; Zain RB
Oral Dis; 2012 Jul; 18(5):469-76. PubMed ID: 22251088
[TBL] [Abstract][Full Text] [Related]
14. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
15. Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas.
Chiang WF; Liu SY; Yen CY; Lin CN; Chen YC; Lin SC; Chang KW
Oral Oncol; 2008 Mar; 44(3):270-6. PubMed ID: 17468034
[TBL] [Abstract][Full Text] [Related]
16. A novel genomic signature reclassifies an oral cancer subtype.
Samman M; Wood HM; Conway C; Stead L; Daly C; Chalkley R; Berri S; Senguven B; Ross L; Egan P; Chengot P; Ong TK; Pentenero M; Gandolfo S; Cassenti A; Cassoni P; Al Ajlan A; Samkari A; Barrett W; MacLennan K; High A; Rabbitts P
Int J Cancer; 2015 Nov; 137(10):2364-73. PubMed ID: 26014678
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
[TBL] [Abstract][Full Text] [Related]
18. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers.
Pickering CR; Zhang J; Yoo SY; Bengtsson L; Moorthy S; Neskey DM; Zhao M; Ortega Alves MV; Chang K; Drummond J; Cortez E; Xie TX; Zhang D; Chung W; Issa JP; Zweidler-McKay PA; Wu X; El-Naggar AK; Weinstein JN; Wang J; Muzny DM; Gibbs RA; Wheeler DA; Myers JN; Frederick MJ
Cancer Discov; 2013 Jul; 3(7):770-81. PubMed ID: 23619168
[TBL] [Abstract][Full Text] [Related]
19. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
[TBL] [Abstract][Full Text] [Related]
20. Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract.
Lin SC; Liu CJ; Chiu CP; Chang SM; Lu SY; Chen YJ
J Oral Pathol Med; 2004 Feb; 33(2):79-86. PubMed ID: 14720193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]